Aura Biosciences Inc
NASDAQ:AURA
Cash Flow Statement
Cash Flow Statement
Aura Biosciences Inc
| Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||
| Net Income |
(23)
|
(29)
|
(35)
|
(48)
|
(47)
|
(54)
|
(59)
|
(63)
|
(68)
|
(71)
|
(76)
|
(79)
|
(81)
|
(83)
|
(87)
|
(95)
|
(101)
|
(106)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
1
|
2
|
2
|
4
|
5
|
6
|
6
|
7
|
7
|
8
|
9
|
10
|
11
|
11
|
12
|
12
|
13
|
14
|
|
| Other Non-Cash Items |
1
|
1
|
2
|
4
|
5
|
5
|
6
|
5
|
6
|
6
|
7
|
8
|
8
|
8
|
9
|
10
|
12
|
14
|
|
| Change in Working Capital |
(0)
|
2
|
(0)
|
(5)
|
(5)
|
(1)
|
(3)
|
1
|
1
|
(1)
|
4
|
(2)
|
(2)
|
0
|
(3)
|
5
|
5
|
3
|
|
| Cash from Operating Activities |
(22)
N/A
|
(24)
-9%
|
(32)
-35%
|
(48)
-47%
|
(47)
+2%
|
(49)
-4%
|
(55)
-12%
|
(56)
-2%
|
(60)
-7%
|
(64)
-8%
|
(64)
+1%
|
(72)
-13%
|
(73)
-2%
|
(73)
+0%
|
(80)
-9%
|
(79)
+1%
|
(83)
-6%
|
(88)
-6%
|
|
| Investing Cash Flow | |||||||||||||||||||
| Capital Expenditures |
(1)
|
(1)
|
(2)
|
(3)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Other Items |
0
|
0
|
0
|
(25)
|
(68)
|
(50)
|
(67)
|
(109)
|
(44)
|
(40)
|
(113)
|
(37)
|
(38)
|
(50)
|
70
|
91
|
90
|
36
|
|
| Cash from Investing Activities |
(1)
N/A
|
(1)
-50%
|
(2)
-48%
|
(28)
-1 197%
|
(70)
-155%
|
(52)
+26%
|
(68)
-31%
|
(109)
-61%
|
(44)
+59%
|
(41)
+8%
|
(114)
-180%
|
(38)
+67%
|
(39)
-4%
|
(51)
-30%
|
69
N/A
|
89
+30%
|
89
+0%
|
35
-60%
|
|
| Financing Cash Flow | |||||||||||||||||||
| Net Issuance of Common Stock |
97
|
93
|
166
|
166
|
79
|
79
|
96
|
96
|
98
|
99
|
97
|
97
|
95
|
94
|
1
|
1
|
71
|
75
|
|
| Other |
(0)
|
(1)
|
(0)
|
(0)
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
97
N/A
|
91
-6%
|
166
+82%
|
166
+0%
|
79
-52%
|
81
+2%
|
96
+19%
|
96
+0%
|
98
+2%
|
100
+2%
|
97
-2%
|
97
+0%
|
95
-2%
|
94
-1%
|
2
-98%
|
1
-10%
|
71
+4 857%
|
75
+5%
|
|
| Change in Cash | |||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
|
| Net Change in Cash |
74
N/A
|
66
-11%
|
132
+100%
|
91
-31%
|
(38)
N/A
|
(20)
+47%
|
(27)
-35%
|
(69)
-158%
|
(6)
+91%
|
(6)
+9%
|
(81)
-1 318%
|
(12)
+85%
|
(18)
-45%
|
(30)
-71%
|
(9)
+69%
|
12
N/A
|
77
+547%
|
22
-71%
|
|
| Free Cash Flow | |||||||||||||||||||
| Free Cash Flow |
(23)
N/A
|
(26)
-11%
|
(35)
-35%
|
(50)
-46%
|
(49)
+3%
|
(50)
-3%
|
(56)
-11%
|
(56)
-1%
|
(61)
-7%
|
(65)
-8%
|
(65)
+1%
|
(73)
-12%
|
(74)
-2%
|
(75)
0%
|
(81)
-9%
|
(80)
+1%
|
(84)
-5%
|
(89)
-5%
|
|